Trupanion (NASDAQ:TRUP) Reaches New 52-Week High on Earnings Beat

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) shares hit a new 52-week high during mid-day trading on Thursday following a stronger than expected earnings report. The stock traded as high as $57.90 and last traded at $56.51, with a volume of 67455 shares traded. The stock had previously closed at $55.12.

The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period last year, the firm earned ($0.10) earnings per share.

Analyst Ratings Changes

Several analysts recently issued reports on TRUP shares. Stifel Nicolaus raised their target price on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Evercore ISI raised Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Northland Securities raised their target price on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday, September 19th. Piper Sandler lifted their price objective on Trupanion from $38.00 to $45.00 and gave the company a “neutral” rating in a research report on Wednesday, October 2nd. Finally, William Blair started coverage on Trupanion in a research report on Friday, July 19th. They set an “outperform” rating on the stock. Four investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $41.83.

Check Out Our Latest Analysis on TRUP

Insider Activity

In other news, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,764 shares of company stock worth $405,238. Insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Trupanion

A number of hedge funds have recently added to or reduced their stakes in TRUP. GAMMA Investing LLC raised its stake in Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after buying an additional 596 shares during the last quarter. Headlands Technologies LLC purchased a new stake in Trupanion during the 2nd quarter valued at $162,000. Handelsbanken Fonder AB purchased a new stake in Trupanion during the 3rd quarter valued at $248,000. Oppenheimer Asset Management Inc. purchased a new stake in Trupanion during the 2nd quarter valued at $235,000. Finally, Bayesian Capital Management LP purchased a new stake in Trupanion during the 1st quarter valued at $253,000.

Trupanion Stock Performance

The business’s 50 day simple moving average is $46.73 and its two-hundred day simple moving average is $35.87. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $2.34 billion, a PE ratio of -86.13 and a beta of 1.73.

About Trupanion

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.